NIH-funded research R21 grant

Effects of organophosphate exposure on brain structure and function

Official title: Inflammation and white matter microstructural alterations after OP exposure

Funded at Henry M. Jackson Fdn for the Adv Mil/med · NIH-10850386 · Data updated 2026-11-12

This study is looking at how being around certain chemicals called organophosphates might change the way our brain's white matter works over time, and it's for anyone interested in understanding the potential risks to brain health from these chemicals and finding ways to help.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionHenry M. Jackson Fdn for the Adv Mil/med
NIH-funded
Lab location1 site (Bethesda, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$254,408
NIH project number1R21NS136126-01
Project IDNIH-10850386 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have been exposed to organophosphate compounds and are experiencing neurological symptoms.

Less likely to help

Patients who have not been exposed to organophosphate compounds or do not exhibit any neurological symptoms may not benefit from this research.

What this research studies

This research investigates how exposure to organophosphate compounds, which can occur in various civilian settings, affects the brain's white matter microstructure. It focuses on the long-term consequences of such exposure, particularly looking at how it alters brain connectivity and function. Using advanced imaging techniques, the study aims to identify the specific changes in brain structure that occur after exposure and to explore potential interventions to mitigate these effects. The research is particularly relevant for understanding the risks associated with organophosphate exposure and developing strategies to protect brain health.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for individuals affected by organophosphate exposure.

How similar studies have gone: Previous research has shown that organophosphate exposure can lead to significant neurological effects, but this specific investigation into white matter microstructural alterations is relatively novel.

Where this research is happening

  • Henry M. Jackson Fdn for the Adv Mil/med
    Bethesda, United States
    Active

Researchers

  • Principal investigator: Marini, Ann M — Henry M. Jackson Fdn for the Adv Mil/med
  • Study coordinator: Marini, Ann M

Related research

Other NIH-funded projects on the same topics.

  • Cooperation partners of SETBP1 in AML development

    This grant explores how SETBP1 and AF9 (MLLT3) work together to drive acute myeloid leukemia and whether targeting related epigenetic regulators could help treat aggressive CK-AML.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11625528

  • U.S. Military HIV Research Program Clinical Trials Unit expansion

    A nationwide network of clinical trial sites is being expanded to test HIV prevention and treatment approaches through DAIDS-supported trials.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11609389

  • Novel protein biomarkers of chronic pain in adults using a pain registry biobank

    A study in adults with chronic pain will look for new protein biomarkers in blood samples to understand better why pain persists and how to improve treatment.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11498721

  • Tailored antibody cures for HIV using AI and vaccines

    A study to design personalized antibody-based strategies to achieve HIV remission, using lab experiments and computer models to tailor vaccines or antibody treatments to individuals or small groups.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11483233

  • Understanding how antibody protection works using 3D protein structures

    Researchers will build a 3D-based method to see which viral features relate to prevention by antibodies, using data from people in HIV vaccine and monoclonal antibody trials.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11470978

  • Military HIV Clinical Network

    This program runs HIV and TB prevention and treatment clinical studies for adults in military-associated and high-HIV-burden communities.

    NIH research Henry M. Jackson Fdn for the Adv Mil/med · Bethesda, United States · NIH-11459071

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.